DESMOPRESSIN ACETATE
| Brand name | NOCDURNA |
|---|---|
| Active ingredient | DESMOPRESSIN ACETATE |
| Strength | 0.0553MG |
| Dosage form | TABLET |
| Route | SUBLINGUAL |
| Modality | Small molecule |
| FDA approval | June 2018 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9974826 | April 2030 | use U-2327 |
| 11963995 | May 2029 | use U-2327 |
| 10137167 | May 2029 | use U-2327 |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.